ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,317.59
-0.26%
Dow Jones
39,069.59
0.01%
Gold vs US Dollar
2,334.20
0.00%
Brent Oil
81.965
0.00%
Bitcoin
68,853.78
-0.60%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Protect Pharmaceutical Corporation (PK) (PRTT)

  7. Protect Pharmaceutical Corporation (PK) (PRTT) News

Protect Pharmaceutical (PK) (PRTT)

Protect Pharmaceutical Corporation (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PRTT
DateTimeSourceHeadlineSymbolCompany
25/09/202013:30InvestorsHub NewsWireProtect Pharmaceuticals Shares Could Soar As Merger Date Approaching SoonUSOTC:PRTTProtect Pharmaceutical Corporation (PK)
12/06/201911:11Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
12/06/201911:11Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
02/04/201917:12Edgar (US Regulatory)Notification That Annual Report Will Be Submitted Late (nt 10-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
06/03/201920:56Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
01/03/201911:33Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
28/02/201914:24Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
21/02/201911:09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
19/02/201911:05Edgar (US Regulatory)Annual Report (10-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
08/02/201920:58Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
07/02/201919:51Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
31/01/201915:54Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
10/12/201811:09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
14/11/201815:49Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
06/06/201814:20Edgar (US Regulatory)Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
05/06/201821:05Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
14/08/201721:57Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
14/07/201719:04MarketwiredStartCapital and Eight Dragons Company Form Contract on Corporate DevelopmentUSOTC:PRTTProtect Pharmaceutical Corporation (PK)
13/07/201716:41Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
07/07/201716:29Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
17/06/201703:54MarketwiredProtect Pharmaceuticals Corporation Changes Business ModelUSOTC:PRTTProtect Pharmaceutical Corporation (PK)
19/05/201718:52Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
15/05/201718:44Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
31/03/201718:28Edgar (US Regulatory)Annual Report (10-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
21/11/201619:40Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
14/11/201619:51Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
20/09/201617:22Edgar (US Regulatory)Current Report Filing (8-k)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
09/09/201621:31Edgar (US Regulatory)Statement Regarding Change in Majority of Directors Pursuant to Rule 14f-1 (sc 14f1)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
15/08/201622:27Edgar (US Regulatory)Quarterly Report (10-q)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
02/06/201620:05Edgar (US Regulatory)Amended Annual Report (10-k/a)USOTC:PRTTProtect Pharmaceutical Corporation (PK)
 Showing the most relevant articles for your search:USOTC:PRTT

Your Recent History

LSE
VAST
Vast Resources
LSE
NG.
National Grid
LSE
CHLL
Chill Brands
LSE
POS
Plexus
LSE
CUSN
Cornish Metals
LSE
LLOY
Lloyds Banking
LSE
RKH
Rockhopper Exploration
LSE
SAR
Sareum
LSE
ITV
Itv
LSE
JSE
Jadestone Energy
LSE
BARC
Barclays
LSE
FDEV
Frontier Developments
LSE
BOO
Boohoo
LSE
INSG
Insig Ai
LSE
GOLD
LSE
OPTI
Optibiotix Health
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved